Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methyl B12 in Children With Autism
NCT01039792Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of mecobalamin in Autism Spectrum Disorder (ASD), sponsored by University of California, San Francisco. Started Jan 2010; status: completed.
02
Drugs
mecobalamin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01039792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039792.